NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Economy

It’s Time to Undo the Harm the CDC Has Done to Pain Patients

by September 24, 2022
written by September 24, 2022
This article appeared in Newsweek on September 21, 2022.

After the U.S. Centers for Disease Control suggested dosage thresholds for patients receiving pain medication in 2016, 38 states rushed to pass legal limits on opioid prescribing and dispensing. Even though the CDC insisted the guidance was “voluntary, rather than prescriptive standards,” states wanted to signal they were being tough on opioids. So they enacted tougher laws, even though CDC guidelines recommended dosing thresholds based upon the “morphine milligram equivalents” (MMEs) of the various opioids, a metric that never made sense, was not evidence‐​based, and amounted to “junk science.”

Learning that its guidelines were being misinterpreted and misapplied, the CDC published an advisory in 2019, emphasizing that it never intended doctors to abruptly taper their patients from their pain medications, some of whom had been flourishing on high‐​dose opioid therapy for years, to its “approved” MME metrics.

But the advisory was too little too late for doctors and patients in states where legislation was already in place.

When a government agency “recommends” a policy, it’s akin to a recommendation from Tony Soprano; it is inevitably interpreted as a mandate, obeyed by state and federal agencies, health insurers, and even pharmacies.

Over the past several months, lawmakers around America have begun re‐​examining existing state laws that have strictly limited and prescribed how health care practitioners can treat pain, which is a clear violation of both physicians’ and patient’s rights.

In Minnesota, for instance, a new law that went into effect Aug. 1 protects health care practitioners from disciplinary action if, based upon their good‐​faith professional judgment, they prescribe opioids to patients with intractable pain, regardless of the dose. Arizona and Alabama have also put in place some incremental reforms this year, although they have yet to enact significant revisions to the opioid prescribing regulations passed based on the CDC’s recommendations.

Those “recommendations” caused millions of patients to suffer. Some, unable to acquire adequate amounts of medication, sought relief in the dangerous black market, where they inadvertently purchased deadly illicit fentanyl. Others were driven to suicide, and some to homicide. Many in the U.S. became so‐​called “pain refugees,” unable to find any doctors to help them. As an unintended consequence, patients are now under‐​treated for acute, even postoperative pain—ridiculous and cruel by any measure.

To justify these cruel policies, we’re often told that prescribing opioids to pain patients caused the overdose crisis. And yet, this “fact”—the basis of the CDC’s advice—turned out to be a fallacy. There turns out to be no correlation between the number of opioid prescriptions and the non‐​medical use of or addiction to prescription pain killers. Data from the National Survey on Drug Use and Health shows that the addiction rate among persons aged 18 and above has remained essentially unchanged throughout the 21st century, despite prescription rates surging to record highs in the early 2000s and then, after 2012, dropping 60 percent.

Despite a huge decrease in opioid prescribing, the overdose rate continues to skyrocket, and modelers predict it will soon dramatically accelerate, as illegal drugs become more potent and deadly.

Responding to complaints by patient advocacy groups, medical scholars, and the American Medical Association, the CDC decided it will publish a revised opioid prescribing guideline by the end of this year. It requested comments on a draft proposal made public last February. We both submitted comments. But no matter how much the CDC stresses that the 2022 revision is merely a recommendation, ill‐​advised laws will be difficult to overturn.

Minnesota lawmakers deserve high marks in undoing some of the harms that the CDC has inflicted on pain patients and their physicians, and hopefully the state’s actions will soon be followed by others. But until the CDC gets out of the business of telling doctors how to practice medicine, none of us can feel safe.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Milk Crate Law?
next post
Here are the worst bank stocks to buy in 2022

You may also like

1619 Project: A Flawed Interpretation With a Hidden...

February 5, 2023

Words, Numbers, and Samuel Gregg

February 4, 2023

The Tragedy of the Monetary Commons

February 4, 2023

Supply Constraints and Inflation, Revisited

February 3, 2023

Efforts to Depoliticize the Fed Will Likely Make...

February 3, 2023

Should the Fed Stop Tightening?

February 2, 2023

The FOMC: To Pause or Not to Pause?

February 2, 2023

An Apostate Indicts Our Educational System

February 1, 2023

The 1519 Project: An Antidote to Caricature?

February 1, 2023

China: House Divided

January 31, 2023
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Popular Posts

  • 1

    My Trigger to Enter $VAPR

  • 2

    Scaling Up Tips From A 24-Year Old Millionaire Trader {VIDEO}

  • 3

    Multi-Millionaire Trader Explains Why You Should Start Trading With A Small Account {VIDEO}

  • 4

    Pay Attention to These Stocks

  • 5

    New ‘Hunger Winter’ Looms as Europe Prepares to Shiver

Recent Posts

  • 1619 Project: A Flawed Interpretation With a Hidden Agenda (Video)

    February 5, 2023
  • Words, Numbers, and Samuel Gregg

    February 4, 2023
  • The Tragedy of the Monetary Commons

    February 4, 2023
  • As Adani implodes, how safe is Reliance Industries stock?

    February 3, 2023
  • Deutsche Bank recommends selling Ford stock after its Q4 results

    February 3, 2023

Categories

  • Economy (609)
  • Editor's Pick (234)
  • Investing (1,613)
  • Stock (9)
  • About Us
  • Email Whitelisting
  • Terms and Conditions
  • Privacy Policy
  • Contacts

Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2023 NewTradingView.com All Rights Reserved.


Back To Top
NewTradingView.com – Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick